实施系统性内镜培养计划以监测内镜再处理效果:结果与成本
本研究以2011至2014年临床微生物数据回顾性排查十二指肠镜相关耐碳青霉烯肠杆菌(CRE)感染,并自2015年6月起对带抬钳器内镜实施每周约25%库存抽样的系统性培养监测。2015年6月至2016年9月共完成285次培养,3次(1.1%)有细菌生长,均为非肠道微生物;20条内镜库存的年估计总成本为30429.60美元。
要点
- 2011至2014年17例CRE感染患者此前36个月内均未接受ERCP或超声内镜。
- 285次培养中3次(1.1%)有细菌生长,2次为皮肤污染菌、1次为口腔污染菌。
- 20条带抬钳器内镜的年估计总成本为30429.60美元,每条内镜1521.48美元。
核心结论
- 这项为期16个月的系统性内镜培养计划评估显示,带抬钳器内镜再处理后培养阳性率低,所有阳性培养均为非肠道微生物。
- 该计划成本适中,并发现了可能使培养阳性率降低的再处理流程。
研究设计与样本
- 基于美国食品药品监督管理局与疾病控制与预防中心(CDC)2015年发布的十二指肠镜培养与再处理指南,实施再处理最佳实践并建立带抬钳器内镜的系统性培养流程。
- 首先回顾性审阅2011至2014年临床微生物数据,评估可能的带抬钳器内镜相关CRE感染;随后实施系统性培养计划,每周按CDC指南对约25%的带抬钳器内镜库存进行培养。
- 培养若回报细菌生长,内镜即被隔离等待重复培养;已计算包括员工时间与耗材在内的计划成本。
主要发现
- 2011至2014年,17例确诊CRE感染患者中无1例在此前36个月内接受过ERCP或超声内镜。
- 2015年6月至2016年9月共完成285次培养,3次(1.1%)有细菌生长,其中2次为皮肤污染菌、1次为口腔污染菌。
- 相关内镜被隔离并再处理,重复培养均为阴性。
- 20条带抬钳器内镜库存的计划年估计总成本为30429.60美元,即每条内镜1521.48美元。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: In 2015, the U.S. Food and Drug Administration and Centers for Disease Control and Prevention (CDC) issued guidance for duodenoscope culturing and reprocessing in response to outbreaks of carbapenem-resistant Enterobacteriaceae (CRE) duodenoscope-related infections. Based on this guidance, we implemented best practices for reprocessing and developed a systematic process for culturing endoscopes with elevator levers. The aim of this study is to report the outcomes and direct costs of this program. METHODS: First, clinical microbiology data from 2011 to 2014 were reviewed retrospectively to assess for possible elevator lever-equipped endoscope-related CRE infections. Second, a program to systematically culture elevator lever-equipped endoscopes was implemented. Each week, about 25% of the inventory of elevator lever-equipped endoscopes is cultured based on the CDC guidelines. If any cultures return bacterial growth, the endoscope is quarantined pending repeat culturing. The costs of the program, including staff time and supplies, have been calculated. RESULTS: From 2011 to 2014, none of 17 patients with documented CRE infection had undergone ERCP or endoscopic ultrasound in the previous 36 months. From June 2015 to September 2016, 285 cultures were performed. Three (1.1%) had bacterial growth, 2 with skin contaminants and 1 with an oral contaminant. The associated endoscopes were quarantined and reprocessed, and repeat cultures were negative. The total estimated cost of our program for an inventory of 20 elevator lever-equipped endoscopes was $30,429.60 per year ($1521.48 per endoscope). CONCLUSIONS: This 16-month evaluation of a systematic endoscope culturing program identified a low rate of positive cultures after elevator lever endoscope reprocessing. All positive cultures were with non-enteric microorganisms. The program was of modest cost and identified reprocessing procedures that may have led to a low rate of positive cultures.
引用
- Ma GK, Pegues DA, Kochman ML, et al. Implementation of a systematic culturing program to monitor the efficacy of endoscope reprocessing: outcomes and costs. Gastrointest Endosc. 2017. PMID: 28499830. doi:10.1016/j.gie.2017.05.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。